# Ypsomed to build first China manufacturing base in Changzhou

Ypsomed signed an agreement to establish its first manufacturing base in China at the Changzhou National Hi-Tech District, with a total investment of over €40 million, focusing on injection pens and needles, expected to start production in 2024.

- Type: New facility
- Announced: 2022-10-27
- Where: Changzhou National Hi-Tech District, Changzhou, China
- Value: $40.0M (40.0M EUR)
- Starts operating: 2024
- Status: announced
- Products: injection pens, injection needles
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [changzhou.gov.cn](https://www.changzhou.gov.cn/ns_news/735166694636517), 2022-10-28: "The program, with a total investment of over 40 million euros, will focus on the R&D, production and assembly of injection pens and needles."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.